Droxinavir (also known as SC 55389A) was an experimental protease inhibitor researched by Pharmacia as a treatment for HIV infection.

Its research and development was discontinued on March 06, 1995.

[1] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.